Medicare Enrolled

Dr. Michael Guma, D.O.

Rheumatology · North Arlington, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
312 BELLEVILLE TPKE, North Arlington, NJ 07031
2019982800
In practice since 2006 (19 years)
NPI: 1376655407 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Guma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guma? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Guma

Dr. Michael Guma is a rheumatology specialist in North Arlington, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Guma performed 3,292 Medicare services across 628 unique beneficiaries.

Between the years covered by Open Payments, Dr. Guma received a total of $20,079 from 45 pharmaceutical and/or device companies across 674 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Guma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 3,292 Medicare services $20,079 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,292
Medicare services
Bottom 42% in NJ for rheumatology
628
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~173 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hymovis intra-articular injection
An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space.
1,008 $13 $45
Denosumab injection (Prolia/Xgeva) 901 $18 $57
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
559 $101 $376
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
186 $67 $259
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
173 $110 $469
Betamethasone steroid injection
An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate.
116 $5 $16
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
90 $26 $97
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
58 $62 $245
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
55 $132 $551
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
47 $116 $432
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
44 $143 $507
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
42 $60 $229
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
13 $13 $69
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.5% high complexity
67.8% medium
25.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$20,079
Total received (2018-2024)
Avg $2,868/year across 7 years
Top 14% in NJ for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
674
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,299 (61.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,780 (38.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$761
2023
$1,309
2022
$2,012
2021
$9,220
2020
$1,475
2019
$3,205
2018
$2,097

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$279
E.R. Squibb & Sons, L.L.C.
$146
ABBVIE INC.
$125
Lilly USA, LLC
$114
GlaxoSmithKline, LLC.
$97
Top 3 companies account for 72.3% of 2024 payments
All-time payments by company (2018-2024) ›
Aurinia Pharma U.S., Inc.
$6,924
Amgen Inc.
$1,781
GENZYME CORPORATION
$1,377
Janssen Biotech, Inc.
$1,254
PFIZER INC.
$914
Novartis Pharmaceuticals Corporation
$835
E.R. Squibb & Sons, L.L.C.
$826
Lilly USA, LLC
$732
GlaxoSmithKline, LLC.
$623
Horizon Therapeutics plc
$561
AbbVie Inc.
$447
ABBVIE INC.
$409
Boehringer Ingelheim Pharmaceuticals, Inc.
$402
Janssen Scientific Affairs, LLC
$339
AbbVie, Inc.
$295
Genentech USA, Inc.
$245
Ferring Pharmaceuticals Inc.
$242
UCB, Inc.
$237
AstraZeneca Pharmaceuticals LP
$205
DePuy Synthes Sales Inc.
$175
MEDEXUS PHARMA, INC.
$155
Sobi, Inc
$110
Octapharma USA, Inc.
$105
Alexion Pharmaceuticals, Inc.
$100
Horizon Pharma plc
$90
FIDIA PHARMA USA INC.
$80
Radius Health, Inc.
$67
SANOFI-AVENTIS U.S. LLC
$65
Mallinckrodt Hospital Products Inc.
$57
Daiichi Sankyo Inc.
$43
Antares Pharma, Inc.
$43
Medtronic Vascular, Inc.
$41
Mallinckrodt LLC
$39
Takeda Pharmaceuticals U.S.A., Inc.
$39
MEDAC PHARMA, INC.
$32
Fresenius Kabi USA, LLC
$30
Zimmer Biomet Holdings, Inc.
$26
Boston Scientific Corporation
$25
SOBI, INC
$25
Fidia Pharma USA Inc.
$19
Hikma Pharmaceuticals USA
$14
Cumberland Pharmaceuticals, Inc.
$13
Kiniksa Pharmaceuticals, Ltd.
$13
Merck Sharp & Dohme Corporation
$11
Organon LLC
$10
Top 3 companies account for 50.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Arcalyst · BENLYSTA · BEVESPI AEROSPHERE · COSENTYX · CUTAQUIG · Cimzia · DUEXIS · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · GENERAL PAIN MANAGEMENT · Gel One · HUMIRA · HYALGAN · HYM/HYN · Humira · Hymovis · INJECTAFER · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Micra · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · Prolia · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TEPEZZA · TREMFYA · Tymlos · Uloric · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in North Arlington?
Compare rheumatologists in the North Arlington area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
384
Per 100K population
40.2
County median income
$123,715
Nearest hospital
CLARA MAASS MEDICAL CENTER
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Guma is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Guma experienced with hymovis intra-articular injection?
Based on Medicare claims data, Dr. Guma performed 1,008 hymovis intra-articular injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Guma receive payments from pharmaceutical companies?
Yes. Dr. Guma received a total of $20,079 from 45 companies across 674 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Guma's costs compare to other rheumatologists in North Arlington?
Dr. Guma's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Guma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →